36th week of 2014 patent applcation highlights part 38 |
Patent application number | Title | Published |
20140249220 | COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF - In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof. | 2014-09-04 |
20140249221 | Tri-Salt Form of Metformin - Provided herein are tri-salt compounds comprising a compound having two acidic functional groups and one basic functional groups (e.g., aspartate or glutamate), metformin, and polyunsaturated fatty acids, such as eicosapentaenoate or docosahexaenoate. The salts can be used in the treatment of diabetes, diabetes with concomitant dyslipidemia (e.g., high triglycerides) and diabetes exacerbated cardiovascular complications, such as cardiac arrhythmia, cardiac ischemia, myocardial infarction, cardiomyopathy, and stroke. The compounds of this invention are also useful in treating obesity. | 2014-09-04 |
20140249222 | METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS - One embodiment of the present invention is to improve the safety and efficacy of the administration of GHB or a salt thereof to a patient. It has been discovered that the concomitant administration of an MCT inhibitor, such as diclofenac, valproate, or ibuprofen, will affect GHB administration. For example, it has been discovered that diclofenac lowers the effect of GHB in the body, thereby potentially causing an unsafe condition. Furthermore, it has been discovered that valproate increases the effect of GHB on the body, thereby potentially causing an unsafe condition. | 2014-09-04 |
20140249223 | METHODS FOR IMPROVING BRAIN DEVELOPMENT AND COGNITIVE FUNCTION USING BETA-HYDROXY-BETA METHYLBUTYRATE - Disclosed are methods for enhancing neural function in an individual, such as an older adult. The methods include administering nutritional compositions comprising HMB to the individual. The nutritional compositions provide benefits for individuals that have or may be at risk of having cognitive decline, cognitive impairment, and neural dysfunction, typically resulting from cognitive diseases associated with neurodegenerative diseases. | 2014-09-04 |
20140249224 | METHODS FOR IMPROVING TOLERANCE, DIGESTION, AND LIPID SOLUBLE NUTRIENT ABSORPTION IN AN INFANT, TODDLER, OR CHILD - Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component. | 2014-09-04 |
20140249225 | METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing or preventing membrane cholesterol domain formation in a subject, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 2014-09-04 |
20140249226 | METHODS OF ADMINISTERING COMPOSITIONS COMPRISING DOCOSAPENTAENOIC ACID - The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (LDL) cholesterol, non-HDL cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid. | 2014-09-04 |
20140249227 | LIPID COMPOSITION FOR THE PREVENTION OR TREATMENT OF SKIN PROBLEMS - The invention relates to a novel lipid composition. Further, the invention relates to the use of a lipid composition for the treatment, alleviation and prevention of skin problems. | 2014-09-04 |
20140249228 | CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA DECARBOXYLASE INHIBITORS, CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND COMPOSITIONS FOR SAME - Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods. | 2014-09-04 |
20140249229 | CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA DECARBOXYLASE INHIBITORS, CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND COMPOSITIONS FOR SAME - Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods. | 2014-09-04 |
20140249230 | Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same - Disclosed herein are compositions that include for example the arginine salt of carbidopa, and methods for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson's disease, secondary parkinsonism, Huntington's disease, Parkinson's like syndrome, PSP, MSA, ALS, Shy-Drager syndrome and conditions resulting from brain injury including carbon monoxide or manganese intoxication, using substantially continuous administration of carbidopa or salt thereof together with administration of levodopa. | 2014-09-04 |
20140249231 | Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same - Disclosed herein are compositions that include for example the arginine salt of carbidopa, and methods for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson's disease, secondary parkinsonism, Huntington's disease, Parkinson's like syndrome, PSP, MSA, ALS, Shy-Drager syndrome and conditions resulting from brain injury including carbon monoxide or manganese intoxication, using substantially continuous administration of carbidopa or salt thereof together with administration of levodopa. | 2014-09-04 |
20140249232 | ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS - Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions. | 2014-09-04 |
20140249233 | METHOD FOR ENHANCING FOLDING AND TRANSPORT OF MISFOLDED GLUCOCEREBROSIDASE - Therapeutic compositions and methods for treatment of late-onset Gaucher disease are described herein. The compositions comprise compounds having activity as pharmacological chaperones for mutant forms of the beta-glucocerebrosidase. Methods of treatment involve providing therapeutically effective amounts of such compositions to subjects in need thereof. | 2014-09-04 |
20140249234 | Compositions and Methods for Restoring the Stratum Corneum and Treating Dermatological Diseases - The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to restore the stratum granulosum and stratum corneum and treat a dermatological disease, such as, for instance atopic dermatitis. More specifically it provides terpenes and terpenoids such as monoterpenoids, sesquiterpenes and norisoprenoids as ingredients that work to restore and thicken the stratum granulosum and stratum corneum and treat a dermatological disease. Terpenes and terpenoid compounds support the cell proliferation, cell differentiation, growth of skin, skin tissue and keratinocytes by upregulating genes for loricrin filaggrin, caspase 14, hornerin and other late cornified envelope components and vascular endothelial growth factor (VEGF) and downregulation of matrix metalloproteinases. Both terpenes and terpenoids may be applied topically or orally at oral or topical concentrations from about 0.6 mg to about 60 mg per kilogram of body weight per day effective to stimulate growth of the skin layer and prevent damage from ultraviolet radiation (UVR). | 2014-09-04 |
20140249235 | Pharmaceutical Compositions With Enhanced Performance and Improved Processability - The presently disclosed and claimed inventive concept(s) relates to a polymer for enhancing drug performance and improving processability. Specifically, the polymer comprises hydroxypropyl methyl cellulose acetate succinate (HPMC-AS). On the HPMC-AS, the percentage of total succinoyl degree of substitution is less than 12% at C6-OH position and greater than 53% at C3-OH, and the percentage of total acetyl degree of substitution is greater than 32% at C6-OH position. | 2014-09-04 |
20140249236 | Salivary mRNA Profiling, Biomarkers and Related Methods and Kits of Parts - A method to detect a biomarker in saliva wherein the biomarker is an extracellular mRNA, comprises detecting the extracellular mRNA in the cell-free saliva; transcriptome analysis of saliva comprises detecting a transcriptome pattern in the cell-free saliva; a method to detect genetic alterations in an organ or in a gene in the organ by analyzing saliva, comprises detecting a transcriptome pattern and/or the mRNA profiling of the gene in cell-free saliva; a method to diagnose an oral or systemic pathology disease or disorder in a subject, comprises: detecting profile of a biomarker associated with the pathology disease or disorder, in particular mRNA and/or protein, in cell-free saliva and/or serum; kits comprising identifier for at least one biomarker for performing at least one of the methods; and use of salivary biomarker salivary and/or serum mRNAs as biomarkers for oral and/or systemic pathology, disease or disorder. | 2014-09-04 |
20140249237 | PRETREATMENT OF BIOMASS USING STEAM EXPLOSION METHODS BEFORE GASIFICATION - An integrated plant that includes a steam explosion process unit and biomass gasifier to generate syngas from biomass is discussed. A steam explosion process unit applies a combination of heat, pressure, and moisture to the biomass to make the biomass into a moist fine particle form. The steam explosion process unit applies steam with a high pressure to heat and pressurize any gases and fluids present inside the biomass to internally blow apart the bulk structure of the biomass via a rapid depressurization of the biomass with the increased moisture content. Those produced moist fine particles of biomass are subsequently fed to a feed section of the biomass gasifier, which reacts the biomass particles in a rapid biomass gasification reaction to produce syngas components. | 2014-09-04 |
20140249238 | TIRE VULCANIZATION/RETREADING SYSTEM USING AUTOCLAVE WITH ELECTROMAGNETIC INDUCTION HEATING - Tire vulcanizing/retreading and de-vulcanization system including an autoclave and heating based on an induction system, which will lead to vulcanization or de-vulcanization of a tire. | 2014-09-04 |
20140249239 | Microporous Polymers, Methods for the Preparation Thereof, and Uses Thereof - A method for preparing a conjugated microporous polymer comprises the coupling of an alkynyl aryl monomer having a plurality of terminal alkyne groups with an iodo- or bromo-aryl monomer having a plurality of halogen atoms in the presence of a palladium (0) catalyst. The conjugated microporous polymer comprises nodes comprising at least one aryl unit and struts comprising at least one alkyne unit and at least one aryl unit, wherein a node is bonded from its aryl unit or units to at least two struts via alkyne units. Such polymers are useful in numerous areas such as separations, controlled release, gas storage and supports for catalysts. | 2014-09-04 |
20140249240 | EXPANDABLE MODIFIED RESIN BEADS, EXPANDED MODIFIED RESIN BEADS, AND FOAMED MOLDED ARTICLE FORMED FROM EXPANDED MODIFIED RESIN BEADS - Disclosed is expandable modified resin beads ( | 2014-09-04 |
20140249241 | OPACIFYING PARTICLES WITH INTERNAL VOID AND METHODS FOR MAKING THE SAME - The invention includes a method of preparing an aqueous dispersion of particles at least partially encapsulated by a polymer, the method comprising dispersing inorganic particles in an aqueous phase; functionalizing at least a portion of the surfaces of the inorganic particles with a coupling agent, the coupling agent having pendent reactive groups; polymerizing the reactive groups on the functionalized particles with a first polymerizable component to produce inner polymer shells surrounding the inorganic particles; polymerizing a second polymerizable component to form outer polymer shells at least partially encapsulating the inner polymer shells; and producing voids within the outer polymer shells, such that the inorganic particles are received within the voids. | 2014-09-04 |
20140249242 | GRAFTING OR CROSSLINKING OF UNSATURATED POLYOLEFINS BY BASE/ISOCYANATE INITIATION - The present invention relates to a novel type of grafting or crosslinking method for (meth)acrylates in which the reaction is initiated by isocyanates and specific bases having an imine structure. Using this novel and specifically applicable method, polymers, particularly polyolefins having double bonds, may be grafted or crosslinked in a suitable reaction procedure. | 2014-09-04 |
20140249243 | PHOTO-CURABLE INK COMPOSITION - A photo-curable ink composition including an acrylic polymer or copolymer, a vinyl ester component, a multifunctional monomer, a photoinitiator and a pigment. Also disclosed herein is a method for forming a printed article and an ink-jet ink printing system using said photo-curable ink composition. | 2014-09-04 |
20140249244 | PHOTOALIGNING MATERIALS - The present invention relates to polymer, homo- or copolymer or oligomer for the photoalignment of liquid crystals, especially for the planar orientation of liquid crystals, comprising a main chain and a side chain, wherein the side chain and/or main chain comprises a polar group, compositions thereof, and its use for optical and electro optical devices, especially liquid crystal devices (LCDs). | 2014-09-04 |
20140249245 | COLOR CHANGING CAULK - A caulk composition having a first color upon application and a second color upon formation of a skin, wherein said skin is suitable for application of a surface treatment. | 2014-09-04 |
20140249246 | MOLDING SAND COMPRISING BIODEGRADABLE POLYMERIC BINDER - Molding sand containing (i) 100 parts by weight of refractory quartz or olivine matrix and (ii) 1 to 5 parts by weight of organic binder. The organic binder contains a mixture of (a) 40-50% w/w aqueous solution of sodium poly(acrylate) in the amount of 30-70% by weight and (b) 40-50% w/w aqueous solution of dextrin in the amount of 30-70% by weight. | 2014-09-04 |
20140249247 | METHOD FOR PREPARING A MASTERBATCH OF DIENE ELASTOMER AND SILICA - Preparation of a masterbatch of diene elastomer and silica including preparing at least one silica dispersion in water; bringing into contact and mixing an elastomer latex and the aqueous silica dispersion in the presence of a metal salt in order to obtain a coagulum; and recovering the coagulum and drying the recovered coagulum in order to obtain the masterbatch. The molar content of zinc cations, defined as the number of moles of zinc cations of the zinc salt per BET unit area of the silica, is between 1.19*10 | 2014-09-04 |
20140249248 | INKJET INK COMPRISING ENCAPSULATED PIGMENT DISPERSIONS WITH TWO ENCAPSULATION STEPS - The present disclosure provides an inkjet ink comprising an aqueous vehicle and an encapsulated pigment dispersion. A process for encapsulating pigment dispersions is provided where a pigment is dispersed with a polymeric dispersant in an aqueous solvent system. The encapsulation process has at least two additions of encapsulating monomers followed by polymerization. To a pigment dispersed with a polymeric dispersant is added an encapsulating monomer(s) and a polymerization initiator is added which forms a stage 1 encapsulated pigment. Then a second encapsulating monomer(s) is added and these monomers are polymerized by a second addition of polymerization initiator, forming a second stage encapsulated pigment. The second encapsulating monomer(s) may be added continuously to the stage 1 encapsulated pigment. Such encapsulated pigment dispersions may be used in inkjet inks and are stable to heat, aging test conditions, and solvent challenges. Prints from these inks have better durability. | 2014-09-04 |
20140249249 | METHOD FOR PREPARING A MASTERBATCH OF DIENE ELASTOMER AND SILICA - Preparation of a masterbatch of diene elastomer and silica including preparing at least one silica dispersion in water; bringing into contact and mixing an elastomer latex and the aqueous silica dispersion in the presence of a calcium salt in order to obtain a coagulum; and recovering the coagulum and drying the recovered coagulum in order to obtain the masterbatch. The molar content of calcium cations, defined as the number of moles of calcium cations of the calcium salt per BET unit area of the silica, is between 1.19*10 | 2014-09-04 |
20140249250 | RUBBER COMPOSITION FABRICATION METHOD AND RUBBER COMPOSITION - A method for producing a rubber composition containing a rubber wet master batch has a masticating process. The masticating process comprises step 1 of charging the rubber wet master batch into an enclosed kneading chamber that has a stirring rotor showing a rotation speed controllable automatically through a control unit and that is capable of detecting and outputting an internal temperature, step 2 of setting a first control time and a first target temperature in the control unit, and step 3 of stirring the inside of the kneading chamber while making a PID control for adjusting an actually measured temperature in the kneading chamber to the first target temperature through the control unit on the basis of information on the actually measured temperature and the first target temperature, thereby automatically controlling the rotation speed, until the first control time elapses after the completion of the two steps. | 2014-09-04 |
20140249251 | METHOD FOR PREPARING A MASTERBATCH OF DIENE ELASTOMER AND SILICA - Preparation of a masterbatch of diene elastomer and silica including preparing at least one silica dispersion in water; bringing into contact and mixing an elastomer latex and the aqueous silica dispersion in the presence of a metal salt having an at least divalent metal element, in order to obtain a coagulum; and recovering the coagulum and drying same in order to obtain the masterbatch. The metal cation molar ration, defined as the number of moles of metal cations of the metal salt per BET unit area of the silica, is between 9.375*10 | 2014-09-04 |
20140249252 | METHOD FOR PRODUCING RUBBER WET MASTERBATCH, RUBBER WET MASTERBATCH, AND RUBBER COMPOSITION INCLUDING RUBBER WET MASTERBATCH - A method for producing a rubber wet masterbatch includes a solidifying step of mixing a slurry solution containing a filler and a dispersing solvent with a rubber latex solution, and solidifying the resultant mixture to produce a filler-containing rubber solidified product, a dehydrating step of using a first uniaxial extruder to dehydrate the filler-containing rubber solidified product while the solidified product is heated into the range of 100 to 180° C., thereby producing a rubber wet masterbatch, and a drying plasticizing step of using a second uniaxial extruder to plasticize the rubber wet masterbatch while the masterbatch is heated into the range of 120 to 180 C, thereby producing the rubber wet masterbatch further decreased in water content by percentage. The method does not have cooling step between the dehydrating step and the drying plasticizing step. | 2014-09-04 |
20140249253 | PHOSPHORUS-CONTAINING COMPOUNDS USEFUL FOR MAKING HALOGEN-FREE, IGNITION-RESISTANT POLYMERS - A process for making a phosphorus-containing compound is disclosed. The process comprises contacting a compound of formula (A) wherein R | 2014-09-04 |
20140249254 | DISPERSING AGENT FOR SOLID SUSPENSIONS - A polymer having the formula (XIV) | 2014-09-04 |
20140249255 | FLAME RETARDANT RESIN COMPOSITION AND MOLDED PRODUCT - A flame retardant resin composition, containing a thermoplastic resin and a flame retardant, wherein the flame retardant contains a nitrogen-containing structure-introduced phosphorylated lignin derivative, wherein the nitrogen-containing structure-introduced phosphorylated lignin derivative is produced by introducing a nitrogen-containing structure into a lignin derivative and adding a phosphoric acid to the lignin derivative, or by adding a phosphoric acid to a lignin derivative and introducing a nitrogen-containing structure into the lignin derivative, or by introducing a nitrogen-containing structure into and adding a phosphoric acid to a lignin derivative simultaneously, and wherein the lignin derivative is obtained by subjecting a naturally occurring lignin to a treatment for allowing the naturally occurring lignin to be decomposed into small molecules or to be water-soluble. | 2014-09-04 |
20140249256 | Texture Material for Covering a Repaired Portion of a Textured Surface - A texture material composition contains, by weight of the texture material, between 11.0% and 72.0% of solvent, between 3.0% and 8.0% of binder, between 0.5% and 3.0% of pigment, between 0.01% and 0.20% of an anti-settling agent, between 0.20% and 3.0% of a dispersant, and between 50.0% and 80.0% of filler. | 2014-09-04 |
20140249257 | Silicone Resins Comprising Metallosiloxane - The invention relates to silicone resins comprising metallosiloxane which contains Si—O-Metal bonds or borosiloxane containing Si—O—B bonds and potentially Si—O—Si and/or B—O—B bonds and containing sulfur. It also relates to the preparation of such silicone resins and to their use in thermoplastic or thermosetting organic polymer or rubber or thermoplastic/rubber blends compositions to reduce the flammability or enhanced scratch and/or abrasion resistance of the organic polymer compositions. It further relates to coatings made of such silicone resins for scratch resistance enhancement or flame retardant properties. | 2014-09-04 |
20140249258 | STYRENE BASED RESIN COMPOSITION, FORMED PARTICLE THEREOF, AND OPTICAL ELEMENT - A styrene based resin composition having a low linear thermal expansion coefficient and high formability, a formed article thereof, and an optical element made from the formed article are provided. The formed article is produced by forming a styrene based resin composition containing a styrene based resin and silica particles, wherein the number average particle diameter of primary particles of the silica particles is 0.5 nm or more and 40 nm or less, and the content of the silica particles is 40 percent by volume or more and 75 percent by volume or less relative to a total of the styrene based resin and the silica particles. | 2014-09-04 |
20140249259 | POLYPROPYLENE RESIN COMPOSITION, POLYOLEFIN RESIN COMPOSITION CONTAINING POLYPROPYLENE RESIN COMPOSITION, AND MOLDED ARTICLE OF POLYOLEFIN RESIN COMPOSITION, - An object of the present invention is to provide a polypropylene resin composition that is blended in a polyolefin resin to improve its surface characteristics and impart sustained water repellency and yet is low in aggregates so as not to deteriorate the visual appearance, a polyolefin resin composition containing the polypropylene resin composition, and a molded article of the polyolefin resin composition. A composition that achieves the object is a polypropylene resin composition obtained by heating and kneading a material containing (A) a polypropylene resin, (B) a polypropylene wax, (C) a polyorganosiloxane containing at least one silicon-atom-bonded alkenyl group in each molecule, and (D) an organic peroxide. | 2014-09-04 |
20140249260 | SWELLABLE ELASTOMERIC POLYMER MATERIALS - The invention is directed to elastomeric polymer materials having controllable swellable properties and to the use of such materials. The invention provides an elastomer composition that comprises an elastomer matrix and a precursor for a swellable compound, which precursor has limited solubility in a fluid such as water and which may be converted into a compound that is soluble in said fluid such as water. The compositions of the invention may be used in a process that comprises bringing the composition to a desired location and converting said precursor into a fluid-soluble compound, while allowing said composition to be in contact with said fluid, prior to, during and/or after said converting of said precursor. | 2014-09-04 |
20140249261 | NANOCOMPOSITE MATERIAL CONTAINING ALUMINA NANOFIBERS AND METHOD FOR MAKING SAME - A method for producing a nanocomposite material reinforced by alumina Al | 2014-09-04 |
20140249262 | APPARATUS AND METHOD FOR PRODUCING COATINGS REINFORCED WITH ALUMINA NANOFIBERS - A method for producing a nanocoating reinforced by alumina Al | 2014-09-04 |
20140249263 | Polymerisable Plasticiser, Liquid Polyurethane Resin Composition Comprising Same and Uses Thereof - The present invention relates to a polymerisable plasticiser formed by a hydrocarbon chain, one end of which bears more than one isocyanate function, said hydrocarbon chain comprising and/or being substituted by an aromatic ring and/or an aliphatic ring and/or said hydrocarbon chain is substituted by at least two hydrocarbon chains that can comprise an unsaturation, and the number of isocyanate functions being strictly greater than 1, preferably greater than 1.2, and, more preferably, grater than 1.5 but less than or equal to 2.2. The invention also relates to liquid polyurethane resin compositions and, in particular, stable, ready-to-use liquid polyurethane resin compositions comprising said plasticiser. The invention further relates to methods for replacing all or part of the exogenous plasticiser and/or solvent in a polyurethane resin by adding said polymerisable plasticiser. | 2014-09-04 |
20140249264 | HIGH-FLUIDITY HETEROPHASIC PROPYLENE COPOLYMER WITH IMPROVED RIGIDITY - Heterophasic propylene copolymers can include a matrix phase and a dispersed phase. The heterophasic propylene copolymers can be characterized by good processability and good mechanical properties, particularly an improved rigidity. The heterophasic propylene copolymers can be well-suited for injection molding applications, particularly for injection molding of thin-walled articles. | 2014-09-04 |
20140249265 | Dispersant Composition - A composition comprising particulate solid (typically a pigment or filler), an organic medium (typically the organic medium may be a plastics material or an organic liquid) and a polyacrylic copolymer. | 2014-09-04 |
20140249266 | POLYURETHANE UREA DISPERSIONS - The present invention relates to aqueous polyurethane urea dispersions based on polyester polyols, which dispersions result in low emissions and are used as coating compositions. | 2014-09-04 |
20140249267 | COLD CONTACT ADHESIVES - An aqueous dispersion comprising at least one polyurethane polymer with a melting temperature in the range of 30° C. to 50° C. and (cold contact) adhesives comprising such a polyurethane dispersion, a method for creating an adhesive bonding and the use of such (cold contact) adhesives for creating an adhesive bonding. | 2014-09-04 |
20140249268 | METHOD FOR MAKING A POLYMER, A POLYMER ARTICLE, A BIODEVICE, AND CYCLIC CARBONATE - The present invention relates to a method for making a polymer wherein during ring opening polymerisation is incorporated into the polymer chain at least one cyclic (alkyl) carbonate monomer having the formula (1) wherein Y is optional and represents the residue of a sulfhydryl reacted group, X represents a functional group reactive with a sulfhydryl group, L=—[CH2]n with n=0-10, or L=−[CH2]p-S—S—[CH2]q with p and q are 0-5 or L=-[PEG]- with PEG is a group that comprises a —[CH2CH2O]m-group with m=1-200, and R2 is hydrogen, methyl or ethyl. Optionally a cyclic (alkyl) acryloyl carbonate, or other additional monomer A may be used as comonomer. The polymer may be formed into a polymer article, such as a polymer film, such as a coating and modified and/or cross linked, to a polymer or polymer article obtainable, and to a biodevice, their use, and to the cyclic (alkyl)carbonates. | 2014-09-04 |
20140249269 | THERMALLY-DETACHABLE SHEET - In order to provide a thermally-detachable sheet that detaches at higher temperatures, this thermally-detachable sheet has a shear bond strength with respect to a silicon wafer of 0.25 kg/5×5 mm or larger, at a temperature of 200° C., after said temperature has been maintained for one minute, and a shear bond strength with respect to a silicon wafer of 0.25 kg/less than 5×5 mm at any temperature in a range of over 200° C. to not more than 500° C., after said temperature has been maintained for three minutes. | 2014-09-04 |
20140249270 | LATEX EMULSIONS AND COATING COMPOSITIONS FORMED FROM LATEX EMULSIONS - Latex emulsions are disclosed which can be used in the formation of coating compositions that are not water sensitive, have good blush resistance and retortability. In some embodiments, the coating compositions are used to coat substrates such as cans and packaging materials for the storage of food and beverages. Coating compositions can be prepared by mixing an ethylenically unsaturated monomer component and a stabilizer comprising a strong acid, in a carrier to form a monomer emulsion, reacting the monomer emulsion with an initiator to form the latex emulsion, and reacting the latex emulsion with a neutralizer. Methods of coating substrates with the coating compositions, and substrates coated with the coating compositions are also disclosed. The latex emulsions can be prepared by mixing an ethylenically unsaturated monomer component and a stabilizer comprising a strong acid, in a carrier to form a monomer emulsion, and reacting the monomer emulsion with an initiator to form the latex emulsion, wherein the stabilizer is present in an amount from about 0.1 to about 2.0 by weight polymeric solids. | 2014-09-04 |
20140249271 | METHOD FOR INCREASING THE REACTIVITY OF LIGNIN - The present invention relates to a method for increasing the reactivity of lignin, wherein the method comprises the following steps: a) forming, under heating at a temperature of 30-70° C., an aqueous dispersion comprising alkali and lignin, wherein the alkali comprises a hydroxide of an alkali metal; and b) heating the dispersion formed in step a) at a temperature of 50-95° C. for producing alkalated lignin. | 2014-09-04 |
20140249272 | EMULSION POLYMERIZATION METHOD USING REACTIVE EMULSIFIER, AQUEOUS POLYMER DISPERSION OBTAINED BY THE SAME, AND POLYMER FILM - An emulsion polymerization is carried out using one or more polymerizable unsaturated monomers X having at least one carbon-carbon double bond in a molecule, one or more reactive emulsifiers Y having at least one polymerizable group in a molecule, and one or more polyfunctional monomers Z1 having two or more polymerizable unsaturated groups in a molecule and having a molecular weight per functional group of less than 150, or one or more hydrophilic monomers Z2 having one polymerizable unsaturated group and a hydrophilic group in a molecule and having an average molecular weight of less than 250, with a proportion of the total mass of the polyfunctional monomer Z1 or hydrophilic monomer Z2 to the total mass of the reactive emulsifier Y being in the range of Z1/Y=1/3 to 1/30 or Z2/Y=1/1 to 1/30. | 2014-09-04 |
20140249273 | SILANE END CAPPED SUBSTITUTED UREA RESINS AND COATINGS THEREOF - The below compound, which may be made by reacting a 3-trialkoxysilylpropyl amine with an acrylic acid ester, a methacrylic acid ester, a diester of maleic acid, a diester of fumaric acid, or acrylonitrile to form a secondary amino propylalkoxysilane, and reacting the secondary amino propylalkoxysilane with an isocyanate. R | 2014-09-04 |
20140249274 | HIGH FUNCTIONALITY ISOCYANATES AS POLYMER POLYOL STABILIZERS AND THE POLYMER POLYOLS PREPARED FROM THESE STABILIZERS - A high functionality macromer that is the reaction product of (1) a polyisocyanate having an NCO group content of about from about 10% to about 33% having a functionality greater than 2, (2) at least one alcohol with reactive unsaturation, and (3) a hydroxyl group-containing polyether having an OH number of from 9 to 60 and a functionality of from 1 to 6 is used to produce a pre-formed stabilizer that is used to produce a high solids content polymer polyol. | 2014-09-04 |
20140249275 | STRAPPING AND METHODS OF MAKING THE SAME - An article includes about 85.5 wt % to about 99.85 wt % of a polyester, and about 0.15 wt % to about 4.5 wt % of a polyolefin co-polymer, where the polyolefin co-polymer is polymerized from monomers including about 10 wt % to about 90 wt % of propylene or one or more (meth)acrylates, and about 10 wt % to about 90 wt % of an olefin other than propylene or a (meth)acrylate, where the article is a strapping article. | 2014-09-04 |
20140249276 | METHOD FOR PRODUCING BRANCHED FUNCTIONALIZED DIENE (CO)POLYMERS - The invention relates to the field of producing synthetic rubbers, in particular diene (co)polymers, such as polybutadiene, polyisoprene and styrene-butadiene rubber (SBR), which can be used in the production of tyres and industrial rubber articles, in the modification of bitumens, in electrical engineering and in other fields. The method consists of a polymerization process or a copolymerization process which is carried out in two parallel reactors, and each of dienes are polymerized or copolymerized with each other and/or with arylvinyl compounds, wherein an organolithium initiator, an electron donor additive and a branching agent are fed into the first reactor, and an organo lithium initiator, an electron donor additive and a functionalizing agent are fed into the second reactor, and the resultant polymerized mixtures are subsequently mixed with each other. This method allows for producing branched functionalized (co)polymers of dienes that are characterized by a statistical distribution of monomer units, a high content of vinyl units (1,2-butadiene units and/or 3,4-isoprene units (more than 60%)), a narrow molecular weight distribution and a controllable content of branched and functionalized parts in the (co)polymer. | 2014-09-04 |
20140249277 | CATALYST COMPOSITIONS AND THEIR USE FOR HYDROGENATION OF NITRILE RUBBER - This invention relates to novel catalyst compositions based on Ruthenium- or Osmium-based complex catalysts and to a process for selectively hydrogenating nitrile rubbers in the presence of such catalyst compositions. | 2014-09-04 |
20140249278 | Novel Ionomer - An ionomer has an ABA-type triblock structure, wherein an A-block is an ionic polymer block including a structural unit having a general formula (i) expressed as follows: —(CH | 2014-09-04 |
20140249279 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT - The invention provides a process for the synthesis of a polycarbonate, the process comprising the step of reacting carbon dioxide with at least one epoxide in the presence of a catalyst of formula (I) and a chain transfer agent. The invention also provides a polymerisation system for the copolymerisation of carbon dioxide and at least one epoxide comprising a catalyst of formula (I) and a chain transfer agent, polycarbonates produced by the inventive process, a block copolymer comprising a polycarbonate produced by the inventive process and a method of producing the same. The invention also relates to novel catalysts of formula (III). | 2014-09-04 |
20140249280 | POLYSILOXANE-POLYCARBONATE COPOLYMER AND METHOD OF MANUFACTURING THE SAME - The present invention relates to a polysiloxane-polycarbonate copolymer and a method of manufacturing the same. More specifically, the present invention relates to a polysiloxane-polycarbonate copolymer in which the molecular weight of the siloxane monomer constituting the copolymer is maintained in a specifically high level and thus excellent low-temperature impact resistance can be achieved even with low siloxane content, and the viscosity of the copolymer is maintained in a low level and thus flowability and moldability can be improved; and a method of manufacturing the same. | 2014-09-04 |
20140249281 | METHOD FOR PREPARATION OF PLATINUM-CARBONYL-SILOXANE COMPOUNDS - The invention relates to a method for preparation of platinum siloxane compounds containing at least one CO ligand molecule (Pt carbonyl siloxanes). The method comprises reacting gaseous carbon monoxide (CO) with a platinum siloxane compound, preferably a platinum vinyl-cyclosiloxane compound, in solution with an organic solvent. The method is straightforward and applicable to industrial scale. With this method, specific isomers of platinum carbonyl vinylcyclosiloxanes are prepared, in which the two η-2-ethenyl groups coordinated to the Pt atom are bonded in trans-configuration relative to the cyclosiloxane backbone. The Pt compounds obtained by the method are used as catalysts for hydrosilylation and for crosslinking and curing of siloxanes and silanes. | 2014-09-04 |
20140249282 | PROCESS FOR THE PREPARATION OF A COPOLYMER OF ETHYLENE - A process for the preparation of an elastomeric polymer of ethylene which comprises polymerizing, in suspension, a mixture of monomers comprising ethylene, at least one a-olefin having from 3 to 12 carbon atoms, possibly at least one non-conjugated diene having from 4 to 20 carbon atoms, in the presence of a catalytic system comprising:—a suspension in oil of at least one catalyst selected from compounds containing vanadium;—-at least one co-catalyst, as such, selected from compounds containing aluminium; at least one activator, as such, selected from compounds containing chlorine. | 2014-09-04 |
20140249283 | BORANE ACTIVATED TITANIUM CATALYST SYSTEM COMPRISING GUANIDINE AND DIENE LIGANDS - The invention relates to a catalyst system for the polymerization of olefms comprising a metal complex of formula and an activating cocatalyst, wherein M is titanium, Cy is a cyclopentadienyl-type ligand, D is a diene, L is a guanidinate-containing ligand of the formula wherein each A is independently selected from nitrogen or phosphorous and R, R | 2014-09-04 |
20140249284 | CROSS-LINKED POLYAMINOCARBOXYLATES FOR THE REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS - The cross-linked polyaminocarboxylates for the removal of metal ions from aqueous solutions of the present invention are cross-linked anionic polyelectrolytes CAPE 6 and CAPE 9, containing pH-responsive amino acid residues. The cross-linked anionic polyelectrolytes have been synthesized via cycloco-polymerization and ter-polymerization of a diallylammonioethanoate monomer (90 mol %) and a cross-linker, 1,1,4,4-tetraallylpiperazinium dichloride (10 mol %) in the absence of SO2 (CAPE 6) and in the presence of SO | 2014-09-04 |
20140249285 | RENEWABLE BIO-BASED (METH) ACRYLATED MONOMERS AS VINYL ESTER CROSS-LINKERS - Anhydrosugar-based monomers prepared from isosorbide, isomannide, and isoidide and resin systems containing these anhydrosugar-based monomers that are partially to fully bio-based, which may produce materials having properties that meet or exceed the properties of similar petroleum derived vinyl ester resins. | 2014-09-04 |
20140249286 | Catalyst Composition Comprising Shuttling Agent for Ethylene Multi-Block Copolymer Formation - A composition for use in forming a multi-block copolymer, said copolymer containing therein two or more segments or blocks differing in chemical or physical properties, a polymerization process using the same, and the resulting polymers, wherein the composition comprises the admixture or reaction product resulting from combining:
| 2014-09-04 |
20140249287 | POLYMER DEGASSING PROCESS CONTROL - The present invention relates to a process for operating a vertical fixed bed polymer powder degasser. | 2014-09-04 |
20140249288 | METHOD FOR PRODUCING ORGANOPOLYSILOXANE - A method of preparing an organopolysiloxane is provided. An organopolysiloxane, which has both a linear or cross-linking structure derived from a trifunctional siloxane unit and a linear structure derived from a difunctional siloxane unit among the molecular structures and also has a sufficiently long linear structure, can be effectively prepared. Also, the organopolysiloxane can be synthesized so that it can have a sufficiently high molecular weight, and a target product showing excellent physical properties can be effectively prepared by minimizing a ratio of a functional group such as an alkoxy group or a hydroxyl group in the synthesized organopolysiloxane. | 2014-09-04 |
20140249289 | METHOD FOR PRODUCING LIGHT-COLOURED POLYISOCYANATES - The invention relates to a method for producing light-coloured polyisocyanates by phosgenation of mixtures comprising MDA and polycyclic aromatic polyamines that have o-phenylenediamine units incorporated via methylene bridges. The invention further relates to the polyisocyanate mixtures obtainable by this method. | 2014-09-04 |
20140249290 | METHODS FOR ENHANCING FLAME RETARDANCE OF MOLDED POLYMERIC MATERIALS - Disclosed are methods for manufacturing molded polymeric articles exhibiting enhanced flame retardant properties. Also disclosed are molded thermoplastic articles manufactured by the disclosed processes and methods. | 2014-09-04 |
20140249291 | METHOD OF MAKING INTEGRATED ION MEMBRANE SEALING RING ASSEMBLY - A method of making a sealing ring ion membrane integrated component, includes: mixing and stirring sulfonic resin with dimethylformamide; filtering the mixed liquid; placing the filtrate in a plastic container for precipitating; the sealing ring into a worktable of a drying apparatus; pouring the precipitated filtrate into the worktable of the drying apparatus, and vacuuming while drying; and taking the dried integrated ion membrane sealing ring assembly out of the drying apparatus, and then cooling the assembly. | 2014-09-04 |
20140249292 | MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY - The invention describes a method for selecting a polypeptide ligand having a desired level of specificity for a target, wherein the polypeptide ligand comprises a polypeptide comprising at least three reactive groups, separated by at least two loop sequences, and a molecular scaffold which forms covalent bonds with the reactive groups of the polypeptide such that at least two polypeptide loops are formed on the molecular scaffold, comprising (i) screening at least two different sets of polypeptide ligands against the target, and selecting one or more ligands from each library which interact with the target; (ii) comparing the activity of the selected ligands with one or more paralogues or orthologues of the target; and (iii) further selecting one or more ligands according to their activity towards said one or more paralogues or orthologues; wherein said two or more different sets of ligands differ in the length of the polypeptide loops formed on the molecular scaffold. | 2014-09-04 |
20140249293 | Absent and Rare Peptides and Therapeutic Uses Thereof - The present invention relates to methods for searching and identifying absent and rare peptide sequences from public databases and their uses in the treatment of pathological diseases. One embodiment of the present invention provides a method that includes: a) storing, in a memory or storage of a computing device, a set of at least one peptide sequence of fixed length; b) searching, by the computing device, for a peptide sequence from the set within at least one database having naturally-occurring amino acid sequences; and c) classifying, by the number of appearance in the database, the peptide sequence. | 2014-09-04 |
20140249294 | PROCESS FOR PRODUCTION OF PEPTIDE THIOESTER - A process for chemically converting a peptide chain into a peptide thioester includes, when a —C(═X)—R | 2014-09-04 |
20140249295 | LIGHT-INDUCIBLE SYSTEM FOR REGULATING PROTEIN STABILITY - Disclosed herein are a light-inducible system and method for rapidly and reversibly modulating protein stability and function. This system and method employs conditionally stable protein domains that regulate the degradation of a fusion protein depending upon the presence or absence of a particular light source. | 2014-09-04 |
20140249296 | USING SORTASES TO INSTALL CLICK CHEMISTRY HANDLES FOR PROTEIN LIGATION - Methods and reagents for the installation of click chemistry handles on target proteins are provided, as well as modified proteins comprising click chemistry handles. Further, chimeric proteins, for example, bi-specific antibodies, that comprise two proteins conjugated via click chemistry, as well as methods for their generation and use are disclosed herein. | 2014-09-04 |
20140249297 | ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS - The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo. | 2014-09-04 |
20140249298 | ANTI-HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 (hENT1) ANTIBODIES ADN METHODS OF USE THEREOF - This invention provides monoclonal antibodies that recognize hENT1. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and/or prophylactic in disorders associated with aberrant hENT1 expression and/or activity. | 2014-09-04 |
20140249299 | HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES - The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes. | 2014-09-04 |
20140249300 | Metal Catalyzed Oxidation of Lignin and Related Compounds - Disclosed are methods for the benzylic oxidation of the lignin and related compounds. The methods include contacting lignin with a mixture containing manganese and iron, in the presence of oxygen to produce a carboxylic acid from lignin or a related compound. In some embodiments, the mixture includes cobalt. | 2014-09-04 |
20140249301 | METHODS FOR ENABLING FARNESENE ACCUMULATION IN PLANTS AND RELATED COMPOSITIONS - The invention provides novel methods and compositions directed to farnesol production, accumulation and cellular sequestration in plants. More specifically, the methods of the invention comprise modifying plant cells that express farnesene to convert the farnesene to farnesol, and in some cases, to farnesol glycoside, such as farnesol glucoside. In other embodiments, carbon flux is shunted towards sesquiterpene production by applying certain plant growth regulators and herbicides to increase sesquiterpene production. | 2014-09-04 |
20140249302 | METHODS FOR MAKING AND USING MOLECULAR SWITCHES INVOLVING CIRCULAR PERMUTATION - The invention provides molecular switches which couple external signals to functionality, and combinatorial methods of making and using the same involving circular permutation of nucleic acid and amino acid sequences. The switches according to the invention can be used, for example, to regulate gene transcription, target drug delivery to specific cells, transport drugs intracellularly, control drug release, provide conditionally active proteins, perform metabolic engineering, and modulate cell signaling pathways. Libraries comprising the switches, expression vectors and host cells for expressing the switches are also provided. | 2014-09-04 |
20140249303 | METHODS FOR DETECTING A POLYMORPHISM IN THE NFKB1 GENE PROMOTER - The present invention discloses a functional relationship between a recognized disease condition and a polymorphism in the nucleotide factor kappa B promoter (NFKB1). This relationship provides a platform for methods of altering promoter activity and for determining similar relationships between specific pathologies and identified polymorphisms. A statistically significant risk of developing ulcerative colitis was shown to be correlated with the presence of an ATTG insertion/deletion in the NFKB1 promoter and is likely to apply also to a variety of other inflammatory diseases. | 2014-09-04 |
20140249304 | LONG INTERFERING DSRNA SIMULTANEOUSLY INDUCING AN IMMUNE REACTION AND THE INHIBITION OF THE EXPRESSION OF TARGET GENES - A long interfering dsRNA (liRNA) capable of inhibiting specific RNAi-mediated expression of target genes and promoting an immune reaction, and use thereof are provided. The long interfering dsRNA can be useful in inhibiting specific expression of target genes through an RNA-interfering reaction in a sequence-specific manner and inducing expression of interferon-β by stimulating a protein kinase R (PKR) path in a structure-dependent manner. | 2014-09-04 |
20140249305 | METHOD FOR PRODUCING HYDROPHILIC CELLULOSE FIBER - The present invention provide a hydrophilized cellulose fiber producing method, comprising oxidizing cellulose fibers in a reaction solution containing a N-oxyl compound, an oxidizing agent, and a co-catalyst and oxidizing other cellulose fibers using the reaction solution again. | 2014-09-04 |
20140249306 | HIV REPLICATION INHIBITOR - The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent. | 2014-09-04 |
20140249307 | METAL COMPLEXES OF CYCLOMETALLATED IMIDAZO[1,2-f]PHENANTHRIDINE AND DIIMIDAZO[1,2-a:1',2'-c]QUINAZOLINE LIGANDS AND ISOELECTRONIC AND BENZANNULATED ANALOGS THEREOF - Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1′,2′-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described. | 2014-09-04 |
20140249308 | ORGANIC ELECTROLUMINESCENT DEVICE - The present invention relates to electronic devices, in particular organic electroluminescent devices, comprising compounds of the formula (1), to the corresponding compounds, and to a process for the preparation of these compounds. | 2014-09-04 |
20140249309 | Method for Preparing Optically Pure (+)-Ambrisentan and (+)-Darusentan - Disclosed is a method for preparing optically pure (+)-ambrisentan and (+)-darusentan, comprising: firstly catalyzing the asymmetric epoxidation of a β-unsaturated alkene using a chiral ketone derived from fructose or a hydrate thereof as a catalyst, and then subjecting the product to an epoxy compound ring-opening reaction and substitution reaction successively to obtain optically pure (+)-ambrisentan and (+)-darusentan. | 2014-09-04 |
20140249310 | Tridentate Platinum (II) Complexes - A platinum (II) complex of general formula (II), | 2014-09-04 |
20140249311 | Iron Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts - A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation reaction. The composition is capable of reacting via hydrosilylation reaction to form a reaction product, such as a silane, a gum, a gel, a rubber, or a resin. Ingredient (A) contains a metal-ligand complex that can be prepared by a method including reacting a metal precursor and a ligand. | 2014-09-04 |
20140249312 | [1,3]DIOXOLO[4,5-G]QUINOLINE-6(5H)THIONE AND [1,3]DIOXOLO[4,5-G][1,2,4]TRIAZOLO[1,5-A]QUINOLINE DERIVATIVES AS INHIBITORS OF THE LATE SV40 FACTOR (LSF) FOR USE IN TREATING CANCER - The present invention relates generally to [1,3]dioxolo[4,5-g]quinoline-6(5H)thione and [1,3]dioxolo[4,5-g][1,2,4]triazolo[1,5-a]quinoline derivatives and/or compositions for use in inhibiting, preventing and/or treating cancer, e.g. hepatocellular carcionoma (HCC). In some embodiments, the invention relates to the use of small-molecule compounds to inhibit, prevent and/or treat expression of the transcription factor Late SV40 Factor (LSF) for treatment of HCC or other cancer types. | 2014-09-04 |
20140249313 | Conjugate Addition Reactions Using Bifunctional Cinchona-Alkaloid-Based Catalysts - One aspect of the present invention relates to quinine-based and quinidine-based catalysts. Another aspect of the present invention relates to a method of preparing a chiral, non-racemic compound from a prochiral electron-deficient alkene, comprising the step of: reacting a prochiral electron-deficient alkene with a nucleophile in the presence of a catalyst; thereby producing a chiral, non-racemic compound; wherein said catalyst is a derivatized quinine or quinidine. | 2014-09-04 |
20140249314 | ISOXAZOLINES FOR CONTROLLING INVERTEBRATE PESTS - Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, | 2014-09-04 |
20140249315 | PROCESSES FOR PREPARING TUBULYSINS - Processes for preparing tubulysins and derivatives thereof are described. In addition, processes for preparing unnatural tubulysins are described. | 2014-09-04 |
20140249316 | ISOXAZOLINE DERIVATIVES AS INSECTICIDES - The present invention relates to compounds formula (I): | 2014-09-04 |
20140249317 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE - Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabilty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form | 2014-09-04 |
20140249318 | THERAPEUTIC AGENT AND PREVENTIVE AGENT FOR DEMYELINATING DISEASE - The object of the present invention is to provide a novel therapeutic or preventive agent for demyelinating disease. The present invention is a therapeutic or preventive agent for demyelinating disease, containing as an active ingredient a 2-phenylthiazole compound represented by Formula (I) | 2014-09-04 |
20140249319 | CHEMICAL CROSSLINKERS AND COMPOSITIONS THEREOF - Chemical crosslinkers and methods of their synthesis are disclosed. | 2014-09-04 |